-
-
-
-
-
-
-
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
-
-
-
-
-
-
-
Vir Biotechnology Provides Updates on Chronic Hepatitis Delta and Oncology Programs and Upcoming 2026 Clinical Milestones
-
-
-
-
-
-
-
Vir Biotechnology Inc. (VIR) Misses Q1 EPS by 1c
-
-
-
-
-
-
-
Vir Biotechnology to Host Virtual Investor Event on PRO-XTEN™ Masked T-Cell Engager Programs
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Vir Biotechnology (VIR)
-
-
-
-
-
-
-
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
-
-
-
-
-
-
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
-
1,199,226 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

